Thyrocare Technologies Fact Sheet, Thyrocare Technologies Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Thyrocare Technologies Fact Sheet    (THYR)


EV Stocks: A Hidden Way to Tap into the Massive 15x EV Opportunity


Here is the latest financial fact sheet of Thyrocare Technologies. For more details, see the Thyrocare Technologies quarterly results and Thyrocare Technologies share price and chart. For a sector overview, read our pharmaceuticals sector report.

THYROCARE TECHNOLOGIES Price History

Price Rs 1,149.2
Mkt Cap Rs m 60,763
Vol '000 12.9
P/E X 36.0
P/CF X 42.3
EPS (TTM) Rs 31.9
% ch % -2.5
No. of shares m 52.87
% ch week % 0.8
% ch 1-mth % -9.4
% ch 12-mth % 4.8
52 week H/L Rs 1,465.9/830.1
(As on Oct 22, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

THYROCARE TECHNOLOGIES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
THYROCARE TECHNOLOGIES EQUITY SHARE DATA
High Rs7437807256891,212 
Low Rs524570482407485 
Sales per share (Unadj.) Rs56.766.376.382.293.6 
Earnings per share (Unadj.) Rs8.017.416.016.621.4 
Diluted earnings per shareRs8.117.716.016.621.4 
Cash flow per share (Unadj.) Rs11.321.121.022.727.1 
Dividends per share (Unadj.) Rs10.0010.0020.005.0025.00 
Adj. dividends per shareRs10.1610.1619.975.0025.00 
Avg Dividend yield %1.61.53.30.92.9 
Book value per share (Unadj.) Rs75.082.081.768.780.3 
Adj. book value per shareRs76.283.381.668.680.3 
Shares outstanding (eoy) m53.7253.7252.8052.8352.87 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x11.210.27.96.79.1 
Avg P/E ratio x79.338.837.732.939.6 
P/CF ratio (eoy) x55.831.928.824.231.3 
Price / Book Value ratio x8.48.27.48.010.6 
Dividend payout %125.357.5124.830.1116.7 
Avg Mkt Cap Rs m34,01636,26131,86428,95544,869 
No. of employees `000NANANANANA 
Total wages/salary Rs m320353434489581 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
THYROCARE TECHNOLOGIES INCOME DATA
Net Sales Rs m3,0443,5634,0294,3434,946 
Other income Rs m12323310167124 
Total revenues Rs m3,1673,7964,1304,4095,071 
Gross profit Rs m8791,4241,5421,6701,713 
Depreciation Rs m181201262319303 
Interest Rs m546199 
Profit before tax Rs m8171,4521,3751,3991,525 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m388517529520393 
Profit after tax Rs m4299358468791,132 
Gross profit margin %28.940.038.338.534.6 
Effective tax rate %47.535.638.537.225.8 
Net profit margin %14.126.221.020.222.9 
THYROCARE TECHNOLOGIES BALANCE SHEET DATA
Current assets Rs m1,4951,4211,3601,5232,381 
Current liabilities Rs m176203206817951 
Net working cap to sales %43.334.228.616.228.9 
Current ratio x8.57.06.61.92.5 
Inventory Days Days13513610294107 
Debtors Days Days81011433 
Net fixed assets Rs m2,8453,3173,3363,1663,020 
Share capital Rs m537537528528529 
"Free" reserves Rs m3,4913,8683,7843,1013,715 
Net worth Rs m4,0284,4054,3123,6294,243 
Long term debt Rs m73025250 
Total assets Rs m4,3404,7384,6964,6895,402 
Interest coverage x177.5330.9226.476.6176.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.80.90.90.9 
Return on assets %10.019.818.119.121.1 
Return on equity %10.621.219.624.226.7 
Return on capital %20.033.131.838.836.2 
Exports to sales %00000 
Imports to sales %0.91.21.20.80.7 
Exports (fob) Rs m00000 
Imports (cif) Rs m2744503533 
Fx inflow Rs m33128526152 
Fx outflow Rs m7244503533 
Net fx Rs m258-1622618 
THYROCARE TECHNOLOGIES CASH FLOW
From Operations Rs m 896 1,070 1,003 1,679 1,160 
From Investments Rs m -415 -432 -116 10 -502 
From Financial Activity Rs m -485 -639 -936 -1,648 -616 
Net Cashflow Rs m -5 -1 -49 41 42 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 66.1%
Institution 19.6%
Non-Institution 14.3%
Total 100.0%
Free Float 33.9%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF D - 37/3 Ttc Industrial Area, M I D C, Turbhe, Navi Mumbai - 400703
E-MAIL investor_relations@thyrocare.com WEB www.thyrocare.com
TEL 022 2762 2762 FAX 022 2768 2409
SECTOR HOSPITAL & HEALTHCARE SERVICES GROUP MNC
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 2000 BSE CODE: 539871 FV (Rs): 10 DIV YIELD (%): 2.2

Read: THYROCARE TECHNOLOGIES 2020-21 Annual Report Analysis

More Hospital & Healthcare Services Company Fact Sheets:   SHALBY   PFIZER  KERALA AYURV  THEMIS MEDICARE  PARMAX PHARMA  

Compare THYROCARE TECHNOLOGIES With:   SHALBY   PFIZER  KERALA AYURV  THEMIS MEDICARE  PARMAX PHARMA  




Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

THYROCARE TECHNOLOGIES 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of THYROCARE TECHNOLOGIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of THYROCARE TECHNOLOGIES. Also includes updates on the valuation of THYROCARE TECHNOLOGIES.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You... (Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally (Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK THYROCARE TECHNOLOGIES

  • Track your investment in THYROCARE TECHNOLOGIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES - APOLLO HOSPITALS COMPARISON

COMPARE THYROCARE TECHNOLOGIES WITH

MARKET STATS